文献速递消化道肿瘤与早癌消化内镜

晚期恶性疾病长期生存患者自膨式食管金属支架的不良事件

Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease.
PubMed 文献 · Gastrointest Endosc · 2016-12-23

该回顾性分析纳入2009年2月至2014年2月在一家三级学术中心因恶性疾病接受食管支架置入且支架留置超过6个月的63例患者,平均随访10.7个月。所有患者均获临床成功,中位支架通畅期7.1个月;40例(63.5%)发生不良事件,共62次,内镜处理成功率为84.5%。多因素分析显示仅体能状态与不良事件相关(P=0.025;风险比4.1)。

要点

  • 支架留置超过6个月的患者中,63.5%(40/63)发生不良事件,平均每例1.5次。
  • 内镜处理不良事件的成功率为84.5%,平均每例再干预1.6次。
  • 多因素分析显示仅体能状态与不良事件相关(P=0.025;风险比4.1)。

核心结论

  • 长期食管支架置入的恶性疾病患者不良事件常见,但不良事件与死亡率升高无关,且大多数不良事件可通过内镜成功处理;仅体能状态是不良事件的危险因素。
  • 作者认为,即使预期生存超过6个月,金属支架置入仍是恶性食管疾病治疗的有效选择。

研究设计与样本

  • 回顾性分析前瞻性收集的数据库,纳入2009年2月至2014年2月在一家三级学术中心因恶性疾病接受食管支架置入且支架留置超过6个月的全部患者。
  • 共纳入63例患者,平均随访10.7个月。

主要发现

  • 全部患者均获得临床成功,中位支架通畅期为7.1个月。
  • 40例患者(63.5%)发生不良事件,共62次不良事件,平均每例1.5次。
  • 内镜处理不良事件的成功率为84.5%,平均每例再干预1.6次。
  • 单因素分析显示体能状态、年龄和支架后放疗呈现不良事件风险升高的趋势。
  • 多因素分析显示仅体能状态与不良事件相关(P=0.025;风险比4.1)。

临床怎么用

  • 作者认为,即使预期生存超过6个月,金属支架置入仍是恶性食管疾病治疗的有效选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Self-expandable metallic stents are considered the best palliative treatment of dysphagia for patients with advanced esophageal cancer. Adverse events (AEs) are a major concern, especially in patients with better prognosis and longer survival. The present study aimed to evaluate the AEs of patients who survived longer than 6 months with esophageal stents in place. METHODS: This is a retrospective analysis of a prospectively collected database including all patients submitted to esophageal stent placement for the palliation of malignant diseases during the period from February 2009 to February 2014 at a tertiary care academic center who had stents longer than 6 months. RESULTS: Sixty-three patients were included. Mean follow-up was 10.7 months. Clinical success was achieved in all patients, and the median stent patency was 7.1 months. AEs occurred in 40 patients (63.5%), totaling 62 AEs (mean, 1.5 AEs per patient). Endoscopic management of AEs was successful in 84.5% of cases, with a mean of 1.6 reinterventions per patient. The univariate analysis revealed that performance status, age, and post-stent radiotherapy presented a trend to higher risk of AEs. The multivariate analysis revealed that only performance status was associated with AEs (P = .025; hazard ratio, 4.1). CONCLUSIONS: AEs are common in patients with long-term esophageal stenting for malignancy. However, AEs were not related to higher mortality rate, and most AEs could be successfully managed by endoscopy. Only performance status was a risk factor for AEs. Our data suggest that metallic stenting is a valid option for the treatment of malignant esophageal conditions, even when survival longer than 6 months is expected.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Medeiros VS, Martins BC, Lenz L, et al. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointest Endosc. 2016. PMID: 28024985. doi:10.1016/j.gie.2016.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。